Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE9386.25223.3 (+2.44 %)

PREV CLOSE ( ) 9162.95

OPEN PRICE ( ) 9170.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1491

TODAY'S LOW / HIGH ( )9170.00 9433.40

52 WK LOW / HIGH ( )6222.35 10653.05

NSE9394.00223.5 (+2.44 %)

PREV CLOSE( ) 9170.50

OPEN PRICE ( ) 9224.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 9394.00 (90)

VOLUME 43419

TODAY'S LOW / HIGH( ) 9221.00 9439.00

52 WK LOW / HIGH ( )6220 10691

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

4804.8

4402.9

4080

3875.2

Total Expenditure

3941.1

3633

3554.6

3494.5

PBIDT (Excl OI)

863.7

769.9

525.4

380.7

Other Income

161.5

79.8

81.5

83.5

Operating Profit

1025.2

849.7

606.90

464.2

Interest

6.8

3.3

3.4

1.1

Exceptional Items

-56.8

-335.5

-575.6

PBDT

961.6

510.9

603.50

-112.5

Depreciation

176.9

90.7

93.2

39.1

Profit Before Tax

784.7

420.2

510.30

-151.6

Tax

202.2

111.7

126

-33.7

Provisions and contingencies

Profit After Tax

582.5

308.5

384.30

-117.9

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

582.5

308.5

384.30

-117.9

Equity Capital

Face Value (IN RS)

Reserves

Calculated EPS

23.3

12.34

15.37

-4.71

Calculated EPS (Annualised)

93.20

49.36

61.48

-18.86

No of Public Share Holdings

6250000

% of Public Share Holdings

PBIDTM% (Excl OI)

17.97

17.48

12.87

9.82

PBIDTM%

21.33

19.29

14.87

11.97

PBDTM%

20.01

11.60

14.79

-2.90

PBTM%

16.33

9.54

12.50

-3.91

PATM%

12.12

7.00

9.41

-3.04

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.